Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Desai RJ, et al. PLoS Med. 2019 Mar 13;16(3):e1002763. doi: 10.1371/journal.pmed.1002763. eCollection 2019 Mar. PLoS Med. 2019. PMID: 30865626 Free PMC article.
BACKGROUND: To the extent that outcomes are mediated through negative perceptions of generics (the nocebo effect), observational studies comparing brand-name and generic drugs are susceptible to bias favoring the brand
BACKGROUND: To the extent that outcomes are mediated through negative perceptions of generics (the nocebo effect), observation …
Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels.
Brito JP, Ross JS, Sangaralingham L, Dutcher SK, Graham DJ, Wang Z, Wu Y, Yao X, Smallridge RC, Bernet V, Shah ND, Lipska KJ. Brito JP, et al. JAMA Netw Open. 2020 Sep 1;3(9):e2017645. doi: 10.1001/jamanetworkopen.2020.17645. JAMA Netw Open. 2020. PMID: 32997127 Free PMC article.
OBJECTIVE: To compare the effectiveness of generic vs brand levothyroxine in achieving and maintaining normal thyrotropin levels among new users. ...These results suggest that generic levothyroxine as initial therapy for mild thyroid dysfunction is as …
OBJECTIVE: To compare the effectiveness of generic vs brand levothyroxine in achieving and maintaining normal thyrotrop …
Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
Luo J, Seeger JD, Donneyong M, Gagne JJ, Avorn J, Kesselheim AS. Luo J, et al. JAMA Intern Med. 2016 Sep 1;176(9):1317-23. doi: 10.1001/jamainternmed.2016.3384. JAMA Intern Med. 2016. PMID: 27367749
OBJECTIVE: To describe trends in the prescribing of generic atorvastatin after expiration of market exclusivity for the brand-name medication and the effect on patients' out-of-pocket spending. ...An interrupted times series model was used to ex …
OBJECTIVE: To describe trends in the prescribing of generic atorvastatin after expiration of market exclusivity for the brand- …